Barclays Maintains Underweight on Illumina, Raises Price Target to $200

Benzinga Newsdesk www.benzinga.com Positive 81.8%

Neg 0% Neu 0% Pos 81.8%

Barclays analyst Luke Sergott maintains Illumina (NASDAQ:ILMN) with a Underweight and raises the price target from $160 to $200.